Streetbeat News

Stock Prices

SWAV

Shockwave Medical's shares surged following the announcement of their Q4 financial results, which exceeded expectations. Additionally, Needham reaffirmed a Buy rating on Shockwave Medical and increased its price target from $260 to $286.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 4:54 pm

TDS

Telephone And Data Systems (TDS) shares are trading lower following the release of their Q4 financial results and the issuance of FY24 guidance.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 4:52 pm

SWTX

Traders are circulating an unconfirmed note suggesting that SpringWorks Therapeutics is seeing takeover interest, which could potentially impact its stock price.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 4:48 pm

AAPL

MSFT

NVDA

SMCI

Nvidia Corp (NVDA) is set to report its Q4 results on February 21, with analysts projecting strong performance and future guidance raises. Wedbush and Oppenheimer analysts have raised their price targets to $800 and $850, respectively, citing high demand in AI infrastructure and data center investments. BofA also maintains a Buy rating with an $800 price target. Nvidia's market cap has reached $1.8 trillion, only behind Microsoft (MSFT) and Apple (AAPL) in the S&P 500, driven by AI enthusiasm. Super Micro Computer Inc (SMCI) also reported sales acceleration due to AI.

Portfolio Pulse from Anusuya Lahiri

February 16, 2024 | 4:47 pm

XOM

A significant bearish sentiment has been observed in the options market for Exxon Mobil (NYSE:XOM), with a notable shift towards puts over calls among large investors. The options activity suggests a price target range of $100 to $110. Despite this, Exxon Mobil's current market performance shows a slight increase in stock price, with analysts providing mixed reviews but leaning towards a positive outlook with an average price target of $122.33.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 4:46 pm

VMC

Vulcan Materials Co (NYSE:VMC) shares surged after reporting strong Q4 FY23 results, with revenue of $1.83 billion and adjusted EPS of $1.46, beating consensus estimates. The company saw significant growth in its Aggregates and Asphalt, Concrete, and Calcium segments, with increased gross profits and margins. Vulcan returned $428 million to shareholders, reported a 34% Y/Y increase in operating cash flow, and provided a positive outlook for 2024, expecting net earnings of $1.07 billion-$1.19 billion and adjusted EBITDA of $2.15 billion-$2.30 billion.

Portfolio Pulse from Lekha Gupta

February 16, 2024 | 4:44 pm

GLUE

Monte Rosa Therapeutics' stock price increased following Wedbush's initiation of coverage with an Outperform rating and a price target of $11.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 4:43 pm

TTD

The Trade Desk, Inc. (NASDAQ:TTD) shares rose after reporting Q4 financial results that exceeded expectations and provided strong guidance. Despite missing EPS estimates, sales outperformed analyst predictions, and the company expanded its share repurchase program. Keybanc upgraded its price target for TTD following these results.

Portfolio Pulse from Erica Kollmann

February 16, 2024 | 4:42 pm

SMCI

Super Micro Computer Inc (NASDAQ:SMCI) experienced a significant drop of nearly 12% on Friday, despite a premarket increase of 5.6% and a record 36% weekly gain. The company, a key player in the AI server market, has seen its stock rise in 18 of the last 20 sessions, with a more than 250% increase this year, following a 246% gain in 2023. Bank of America initiated coverage with a buy rating, and Wells Fargo Securities started with an equal-weight rating. Despite some analysts' concerns about the stock being overbought, Super Micro's focus on AI and engineering has driven its valuation to over $56 billion, making it the S&P Midcap 400 Index's top performer.

Portfolio Pulse from Anusuya Lahiri

February 16, 2024 | 4:39 pm

RILY

B. Riley Financial, Inc. (NASDAQ:RILY) shares dropped over 7% following a critical report by The Bear Cave, which B. Riley has since addressed. The report raised concerns about the departure of their audit partner at Marcum LLP, the collateral of a significant loan, and regulatory matters. B. Riley refuted these claims, stating they maintain a first lien on the loan's collateral and accusing The Bear Cave of market manipulation.

Portfolio Pulse from Erica Kollmann

February 16, 2024 | 4:33 pm